- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
74 |
|
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
|
– The degree of renal damage generally is |
3.4 |
Etiology of PUJ Obstruction |
less than that of intrinsic obstruction |
|
|
because the pressure damage is only evi- |
• There are several causes of PUJ obstruction |
|
dent intermittently. |
and these can be divided into two groups, pri- |
|
• This obstructive nephropathy is progressive if |
mary and secondary causes. |
|
the PUJ obstruction is not relived and this |
• Primary causes include (Figs. 3.4 and 3.5): |
|
manifest in progressive deterioration of the |
– |
Intrinsic obstruction from stenosis at the |
renal function (Figs. 3.2 and 3.3). |
|
PUJ due to scarring of ureteral valves. |
• Sometimes, the obstructive nephropathy will |
– An abnormal or high insertion of the ureter |
|
progress and becomes irreversible in spite of |
|
into the renal pelvis. This is controversial |
relive of the PUJ obstruction. |
|
ad many consider this a secondary phe- |
• There is also activation of the renin- |
|
nomenon to obstruction. |
angiotensin system and administration of the |
– Ureteral hypoplasia may result in abnormal |
|
angiotensin-converting enzyme (ACE) inhibi- |
|
peristalsis through the PUJ. |
tors has been shown to maintain renal blood |
– |
Asymmetry of ureteral wall musculature |
flow and prevent the histologic changes of |
|
may inhibit the natural peristaltic emptying |
glomerulosclerosis. |
|
of the renal pelvis into the ureter. |
• The long-term effects of PUJ obstruction on |
• Secondary causes include (Figs. 3.6, 3.7, 3.8, |
|
the kidney are quite variable and depend on |
3.9, 3.10, 3.11 and 3.12): |
|
several factors including: |
– Crossing lower-pole renal vessel(s). |
|
– The variability in the degree of |
– |
Fibrous bands |
obstruction |
– |
Kinks |
– The timing of the obstruction |
– Horseshoe or pelvic kidney |
|
– The ability of the renal pelvis and renal col- |
– |
Duplex collecting systems |
lecting system and renal parenchyma to |
– Rotational abnormalities of the kidney |
|
adjust to the changes associated with |
– Renal hypermobility can cause intermittent |
|
obstruction. |
|
obstruction that is solely dependent on the |
– Early PUJ obstruction causes severe mal- |
|
position of the kidney relative to the ureter. |
formation of the kidney (dysplasia), |
– |
Secondary PUJ obstruction can be caused |
whereas late occurring PUJ obstruction |
|
by prior surgical intervention to treat other |
may not affect the kidney as severely. |
|
renal disorders (e.g., renal stone) |
Figs. 3.2 and 3.3 Abdominal CT-scan in two children with PUJ obstruction (Note the sever renal atrophy in the first CT as a result of progressive dilatation of the renal
pelvis and pressure on the renal parenchyma while in the second one there is relative preservation of the renal parenchyma)
3.4 Etiology of PUJ Obstruction |
75 |
|
|
Figs. 3.4 and 3.5 Contrast studies through a nephrostomy tube for two children with PUJ obstruction (Note the normally inserted ureter in the right picture and the highly
inserted ureter in the left picture. Many feel that the high insertion of the ureter is secondary to the dilated renal pelvis rather the primary cause of PUJ obstruction)
KINKED
URETER
KINKED
URETER
Figs. 3.6 and 3.7 Contrast studies through a nephrostomy tube in two children with PUJ obstruction (Note the kinked ureters in both but it is difficult to decide whether this is the cause or it is secondary to PUJ obstruction)
– |
Failed repair of a primary PUJ obstruction. |
– Ureteral-wall and periureteral scar forma- |
– |
Inflammation at the PUJ secondary to an |
tion as a result of inflammation or prior sur- |
|
obstructing stone. |
gical repair. |
76 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
DILATED RENAL PELVIS
DILATED RENAL PELVIS
URETER
Figs. 3.8, 3.9, and 3.10 A contrast study and intraoperative photographs of a child with a hydronephrotic pelvic kidney secondary to PUJ obstruction that was also malrotated
•Aberrant polar vessels may also cause compression and obstruction of the PUJ.
•The end result of PUJ obstruction depends on the severity of obstruction. This will lead to the following changes:
–Impaired urinary drainage
–Elevated intrarenal back pressure
–Dilatation of the renal pelvis and collecting system, and hydronephrosis
–Back pressure on the renal parenchyma
–Progressive renal damage and renal deterioration
3.5Clinical Features
•PUJ obstruction is the most common cause of neonatal and antenatal hydronephrosis, occurring in 1 per 1,000–1,500 live births.
•The presentation of PUJ obstruction is also variable.
•Neonates with PUJ obstruction are usually asymptomatic and the majority present with hydronephrosis that was diagnosed in utero by an antenatal ultrasound.
3.5 Clinical Features |
77 |
|
|
ABERRANT
POLAR VESSEL
URETER
DIVIDED
URETER
DILATED RENAL
PELVIS
Figs. 3.11 and 3.12 Intraoperative photographs showing hydronephrosis secondary to an aberrant lower polar vessel. Note the vessel compressing the ureter in the upper
photograph. Note also the associated hydronephrosis following division of the ureter
• |
Prior |
to the use of prenatal ultrasonography, |
|
• Renal failure is an unusual presentation, |
|
|
most patients with PUJ obstruction present with: |
|
and occurs in infants with a single |
||
|
– |
Pain |
|
obstructed kidney or with bilateral |
|
|
– |
Hematuria |
|
severe hydronephrosis. |
|
|
– |
Urinary tract infection |
• Older children may present with: |
||
|
– |
Failure to thrive |
– The presentation of patients with PUJ is vari- |
||
|
– |
A palpable mass |
|
able depending on the severity of obstruction. |
|
• Currently, with the availability and routine use |
– Intermittent back pain, flank pain or |
||||
|
of |
|
prenatal ultrasonography, urologic |
|
abdominal pain |
|
abnormalities including PUJ obstruction are |
– The pain may worsen during brisk diuresis |
|||
|
being diagnosed earlier and more frequently. |
– |
Abdominal pain may be accompanied by |
||
• |
50 % |
of patients diagnosed with antenatal |
|
nausea and vomiting |
|
|
hydronephrosis are eventually diagnosed with |
– A detailed history may reveal that the pain |
|||
|
PUJ obstruction upon further workup. |
|
correlates with periods of increased fluid |
||
• Fetal and neonatal hydronephrosis: |
|
intake or ingestion of a food with diuretic |
|||
|
– |
Most cases of PUJ obstruction are diag- |
|
properties (i.e. Dietl’s crisis). |
|
|
|
nosed antenatally during routine antenatal |
– |
Urinary tract infection |
|
|
|
ultrasound. |
– |
A flank mass representing the hydrone- |
|
|
– |
These cases are confirmed by postnatal |
|
phrotic kidney |
|
|
|
ultrasound. |
– The enlarged kidney is vulnerable to trau- |
||
|
– Newborns may present with: |
|
matic injury (Figs. 3.13, 3.14 and 3.15) |
||
|
|
• A palpable abdominal mass caused by |
– |
Hematuria |
|
|
|
|
an enlarged obstructed kidney. |
– |
Renal calculi |
|
|
• |
Urinary tract infection |
– |
Hypertension |
|
|
• |
Hematuria |
– |
An incidental finding on abdominal ultra- |
|
|
• |
Failure to thrive |
|
sound evaluation |
78 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
Figs. 3.13, 3.14, and 3.15 Abdominal CT-scans showing trauma and rupture of a hydronephrotic kidney in a child with PUJ obstruction
•Initially, most children diagnosed to have PUJ obstruction are treated conservatively and monitored closely.
•Surgical intervention is indicated in symptomatic patients and those with significantly impaired renal drainage and decreased renal function.
•The presence of significant hydronephrosis on antenatal ultrasound is based on the followings:
–The anteroposterior diameter of the renal pelvis is more than 10 mm.
–The ratio of the renal pelvis to the anteroposterior kidney is more than 0.3.
– Evidence of caliectasis is present after 24 weeks of gestation.
•A follow-up postnatal ultrasound should be performed 36–48 h after birth to avoid the transient neonatal dehydration.
•Earlier postnatal ultrasound (24–48 h) is performed for those with severe PUJ obstruction.
–Those with very large renal pelvis
–Those with bilateral hydronephrosis
–Those with solitary kidney
–Those with PUJ obstruction and oligohydramnios
•The most widely used grading system of the severity of hydronephrosis on ultrasonography after birth is SFU (Society for Fetal Urology) system, rather than the anteroposterior diameter of the renal pelvis.
•The SFU grading system for hydronephrosis is as follows :
–Grade 0:
•No hydronephrosis, intact central renal complex seen on ultrasonography
–Grade 1: